Khemraj Hirani

Dr. Khemraj Hirani is a Research Assistant Professor at the Department of Medicine, Miller School of Medicine, University of Miami. He serves as Associate Vice Chair for Research and Regulatory Compliance, Deputy Director and Chief Operating Officer at the Diabetes Research Institute, and Associate Director of the Office of Executive Dean of Research.

• Education: Valedictorian at Mangalore University (Diploma and Bachelor’s in Pharmacy), Nagpur University (Master’s and Ph.D. in Pharmacology), and Indian Institute of Modern Management (Postgraduate Diploma in Business Management).

Dr. Hirani’s research focuses on Type 1 Diabetes (T1D), emphasizing genetic-environmental interactions, immune response mechanisms, and advanced biomaterials for islet transplantation. He integrates precision medicine and machine learning into diabetes diagnostics, while his work in regulatory science optimizes clinical trial designs for faster translation of therapies.

His publications highlight trends in neuromodulation for diabetic complications, leptin-dopamine interactions in comorbidities, anti-VEGF treatments for retinopathy, gene therapy for beta-cell preservation, and AI-driven early diabetes detection. Articles also explore hypoxia-immune-metabolic interplay in T1D and gestational diabetes management.

Dr. Hirani mentors graduate and postgraduate students, emphasizing ethical research practices and regulatory compliance. His leadership roles in academic and biotech ventures, including co-founding Prizm Therapeutics and Ambulero Inc., underscore his commitment to curative therapies for diabetes and rare pediatric diseases.